Citing the reason behind its observation, the credit rating firm in its report said that despite India exporting over half of ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...

We previously reported on an uptick in the passage of state drug price transparency legislation. What follows is an update to that report. As of ...

Sri Lanka’s drive to boost local pharmaceutical manufacturing is running up against a critical bottleneck: the scarcity of ...

President Trump’s aim to slash U.S. prescription drug prices by 50% is unlikely to materialize, according to analysts at Capital Economics.

Prescription drugs prices have rapidly increased, but opting for generic medications and incorporating lifestyle changes are some ways to cut costs.

NPPA sets retail prices for 41 drug combinations, including 18 variants of off-patent diabetes drug empagliflozin, following steep price drops post-patent expiry ...

The pharmaceutical excipients market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the increasing demand ...

Prescription drug cost barriers are increasingly causing people to divert from doctor-recommended treatment plans.

By a News Reporter-Staff News Editor at Health Policy and Law Daily-- A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic medicines ...

President Trump issued Executive Order 14297 targeting prescription drug prices in America. The stated purpose of this order is ...